Bionano Genomics Inc
(BNGO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2018 | 12-2017 | 09-2017 | 12-2016 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 0 | N/A | 0 | 5,240 |
| Receivables | 0 | N/A | 0 | 1,840 |
| Inventories | 0 | N/A | 0 | 1,790 |
| Other current assets | 0 | 0 | 0 | 1,860 |
| TOTAL | $0 | $N/A | $0 | $10,730 |
| Non-Current Assets | ||||
| PPE Net | N/A | N/A | N/A | 6,460 |
| TOTAL | $N/A | $N/A | $N/A | $6,460 |
| Total Assets | $0 | $N/A | $0 | $14,780 |
| Liabilities | ||||
| Current Liabilities | ||||
| Short Term Debt | 0 | N/A | 0 | 580 |
| Accounts payable and accrued liabilities | 0 | 0 | 0 | 790 |
| Accrued Expenses | 0 | N/A | 0 | 2,880 |
| Other current liabilities | 0 | N/A | 0 | 5,090 |
| TOTAL | $0 | $N/A | $0 | $9,360 |
| Non-Current Liabilities | ||||
| Long Term Debt | 0 | N/A | 0 | 6,040 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 26,380 |
| TOTAL | $N/A | $N/A | $N/A | $32,660 |
| Total Liabilities | $0 | $N/A | $0 | $42,040 |
| Shareholders' Equity | ||||
| Retained earnings | 0 | N/A | 0 | -30,900 |
| Other shareholders' equity | 0 | 0 | 0 | 10 |
| TOTAL | $0 | $N/A | $0 | $-27,250 |
| Total Liabilities And Equity | $0 | $0 | $0 | $14,790 |